Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. (Q34132177)

31 July 2017

0 references

Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. (English)

1 reference

31 July 2017

0 references

1 reference

0 references

1 reference

Kathryn H Jacobsen

1

0 references

author name string

Steven T Wiersma

series ordinal

2

1 reference

PubMed ID

20723630

31 July 2017

language of work or name

English

0 references

publication date

17 August 2010

1 reference

31 July 2017

1 reference

31 July 2017

28

1 reference

31 July 2017

6653-6657

1 reference

31 July 2017

41

1 reference

Hepatitis A in the era of vaccination

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Declining hepatitis A seroprevalence: a global review and analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Hepatitis A and E: update on prevention and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Hepatitis A: old and new.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Clinical course and consequences of hepatitis A infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

The epidemiology of hepatitis A virus infections in four Pacific Island nations, 1995-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Racial differences in the seroprevalence of hepatitis A virus infection in Natal/KwaZulu, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Incidence of Hepatitis A in Argentina after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.037

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2010.08.037

1 reference

31 July 2017

1 reference

PubMed ID

20723630